Victor Okunrintemi1, Erica S Spatz1, Paul Di Capua1, Joseph A Salami1, Javier Valero-Elizondo1, Haider Warraich1, Salim S Virani1, Michael J Blaha1, Ron Blankstein1, Adeel A Butt1, William B Borden1, Kumar Dharmarajan1, Henry Ting1, Harlan M Krumholz1, Khurram Nasir2. 1. From the Center for Healthcare Advancement and Outcomes (V.O., J.A.S., J.V.-E., K.N.) and Miami Cardiac and Vascular Institute (K.N.), Baptist Health South Florida, Miami; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT (E.S.S., K.D., H.M.K.); Section of Cardiovascular Medicine, Yale University, New Haven, CT (E.S.S.); Department of Internal Medicine, Baptist Health Medical Group, Miami, FL (P.D.C.); Department of Epidemiology, Robert Stempel College of Public Health and Social Work (K.N.) and Department of Medicine, Herbert Wertheim College of Medicine (K.N.), Florida International University, Miami; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC (H.W.); Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX (S.S.V.); Baylor College of Medicine, Houston, TX (S.S.V.); Brigham and Women's Hospital, Boston, MA (R.B.); Department of Medicine, Hamad General Hospital, Doha, Qatar (A.A.B.); Healthcare Delivery Transformation, George Washington University, DC (W.B.B.); New York-Presbyterian/Columbia University Medical Center (H.T.); and Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD (M.J.B., K.N.). 2. From the Center for Healthcare Advancement and Outcomes (V.O., J.A.S., J.V.-E., K.N.) and Miami Cardiac and Vascular Institute (K.N.), Baptist Health South Florida, Miami; Center for Outcomes Research and Evaluation, Yale New Haven Hospital, New Haven, CT (E.S.S., K.D., H.M.K.); Section of Cardiovascular Medicine, Yale University, New Haven, CT (E.S.S.); Department of Internal Medicine, Baptist Health Medical Group, Miami, FL (P.D.C.); Department of Epidemiology, Robert Stempel College of Public Health and Social Work (K.N.) and Department of Medicine, Herbert Wertheim College of Medicine (K.N.), Florida International University, Miami; Department of Medicine, Division of Cardiology, Duke University Medical Center, Durham, NC (H.W.); Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX (S.S.V.); Baylor College of Medicine, Houston, TX (S.S.V.); Brigham and Women's Hospital, Boston, MA (R.B.); Department of Medicine, Hamad General Hospital, Doha, Qatar (A.A.B.); Healthcare Delivery Transformation, George Washington University, DC (W.B.B.); New York-Presbyterian/Columbia University Medical Center (H.T.); and Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University, Baltimore, MD (M.J.B., K.N.). KhurramN@baptisthealth.net.
Abstract
BACKGROUND: Consumer-reported patient-provider communication (PPC) assessed by Consumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a complementary value metric for patient-centered care of chronic conditions in pay-for-performance programs. In this study, we examine the relationship of PPC with select indicators of patient-centered care in a nationally representative US adult population with established atherosclerotic cardiovascular disease. METHODS AND RESULTS: The study population consisted of a nationally representative sample of 6810 individuals (aged ≥18 years), representing 18.3 million adults with established atherosclerotic cardiovascular disease (self-reported or International Classification of Diseases, Ninth Edition diagnosis) reporting a usual source of care in the 2010 to 2013 pooled Medical Expenditure Panel Survey cohort. Participants responded to questions from Consumer Assessment of Health Plans Survey that assessed PPC, and we developed a weighted PPC composite score using their responses, categorized as 1 (poor), 2 (average), and 3 (optimal). Outcomes of interest were (1) patient-reported outcomes: 12-item Short Form physical/mental health status, (2) quality of care measures: statin and ASA use, (3) healthcare resource utilization: emergency room visits and hospital stays, and (4) total annual and out-of-pocket healthcare expenditures. Atherosclerotic cardiovascular disease patients reporting poor versus optimal were over 2-fold more likely to report poor outcomes; 52% and 26% more likely to report that they are not on statin and aspirin, respectively, had a significantly greater utilization of health resources (odds ratio≥2 emergency room visit, 1.41 [95% confidence interval, 1.09-1.81]; odds ratio≥2 hospitalization, 1.36 [95% confidence interval, 1.04-1.79]), as well as an estimated $1243 ($127-$2359) higher annual healthcare expenditure. CONCLUSIONS: This study reveals a strong relationship between PPC and patient-reported outcomes, utilization of evidence-based therapies, healthcare resource utilization, and expenditures among those with established atherosclerotic cardiovascular disease.
BACKGROUND: Consumer-reported patient-provider communication (PPC) assessed by Consumer Assessment of Health Plans Survey in ambulatory settings is incorporated as a complementary value metric for patient-centered care of chronic conditions in pay-for-performance programs. In this study, we examine the relationship of PPC with select indicators of patient-centered care in a nationally representative US adult population with established atherosclerotic cardiovascular disease. METHODS AND RESULTS: The study population consisted of a nationally representative sample of 6810 individuals (aged ≥18 years), representing 18.3 million adults with established atherosclerotic cardiovascular disease (self-reported or International Classification of Diseases, Ninth Edition diagnosis) reporting a usual source of care in the 2010 to 2013 pooled Medical Expenditure Panel Survey cohort. Participants responded to questions from Consumer Assessment of Health Plans Survey that assessed PPC, and we developed a weighted PPC composite score using their responses, categorized as 1 (poor), 2 (average), and 3 (optimal). Outcomes of interest were (1) patient-reported outcomes: 12-item Short Form physical/mental health status, (2) quality of care measures: statin and ASA use, (3) healthcare resource utilization: emergency room visits and hospital stays, and (4) total annual and out-of-pocket healthcare expenditures. Atherosclerotic cardiovascular diseasepatients reporting poor versus optimal were over 2-fold more likely to report poor outcomes; 52% and 26% more likely to report that they are not on statin and aspirin, respectively, had a significantly greater utilization of health resources (odds ratio≥2 emergency room visit, 1.41 [95% confidence interval, 1.09-1.81]; odds ratio≥2 hospitalization, 1.36 [95% confidence interval, 1.04-1.79]), as well as an estimated $1243 ($127-$2359) higher annual healthcare expenditure. CONCLUSIONS: This study reveals a strong relationship between PPC and patient-reported outcomes, utilization of evidence-based therapies, healthcare resource utilization, and expenditures among those with established atherosclerotic cardiovascular disease.
Authors: Victor Okunrintemi; Javier Valero-Elizondo; Erin D Michos; Joseph A Salami; Oluseye Ogunmoroti; Chukwuemeka Osondu; Martin Tibuakuu; Eve-Marie Benson; Timothy M Pawlik; Michael J Blaha; Khurram Nasir Journal: J Gen Intern Med Date: 2019-09-05 Impact factor: 5.128
Authors: Victor Okunrintemi; Rohan Khera; Erica S Spatz; Joseph A Salami; Javier Valero-Elizondo; Haider J Warraich; Salim S Virani; Ron Blankstein; Michael J Blaha; Timothy M Pawlik; Kumar Dharmarajan; Harlan M Krumholz; Khurram Nasir Journal: J Gen Intern Med Date: 2019-02-19 Impact factor: 5.128
Authors: Stephanie Navarro; Xiaohui Hu; Aaron Mejia; Carol Y Ochoa; Trevor A Pickering; Leslie Ballas; Albert J Farias Journal: Cancer Causes Control Date: 2022-01-15 Impact factor: 2.506
Authors: Christoph Gross; Theresa Schachner; Andrea Hasl; Dario Kohlbrenner; Christian F Clarenbach; Forian V Wangenheim; Tobias Kowatsch Journal: J Med Internet Res Date: 2021-05-26 Impact factor: 5.428
Authors: Christine Eichelberger; Aarti Patel; Zhijie Ding; Christopher D Pericone; Jennifer H Lin; Christopher W Baugh Journal: Cardiol Ther Date: 2020-03-02